Epithelial-mesenchymal transition and colorectal cancer: Gaining insights into tumor progression using LIM 1863 cells

Cells Tissues Organs

Volumn 185, Issue 1-3, 2007, Pages 29-39

  Bates, Richard C ^a   Pursell, Bryan M ^a   Mercurio, Arthur M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Colorectal cancer; Cytokines; Epithelial mesenchymal transition; Integrins; Tumor progression

Indexed keywords

ALPHAVBETA6 INTEGRIN; INTEGRIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APOPTOSIS; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL INTERACTION; CELL MIGRATION; CELL SURVIVAL; CELL TRANSFORMATION; CHEMICAL ANALYSIS; COLON TUMOR; COLORECTAL CANCER; CONFERENCE PAPER; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; MESENCHYME CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTOKINES; DISEASE PROGRESSION; EPITHELIAL CELLS; EPITHELIUM; HUMANS; INTEGRINS; MESODERM; MODELS, BIOLOGICAL;

EID: 34250769394     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101300     Document Type: Conference Paper

References (85)

1. Andre, T., L. Kotelevets, J.C. Vaillant, A.M. Coudray, L. Weber, S. Prevot, R. Parc, C. Gespach, E. Chastre (2000) Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer 86: 174-181.
2. Arias, A.M. (2001) Epithelial mesenchymal interactions in cancer and development. Cell 105: 425-431.
3. Baier, P.K., G. Wolff-Vorbeck, S. Eggstein, U. Baumgartner, T.U. Hopt (2005) Cytokine expression in colon carcinoma. Anticancer Res 25: 2135-2139.
4. Barth, R.J., Jr., B.J. Camp, T.A. Martuscello, B.J. Dain, V.A. Memoli (1996) The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival. Cancer 78: 1168-1178.
5. Bates, R.C. (2003) Gastrointestinal matrix, organization and significance; in Johnson, L.R. (ed): Encyclopedia of Gastroenterology. San Diego, Elsevier Science, pp 219-223.
6. Bates, R.C., A. Buret, D.F. van Helden, M.A. Horton, G.F. Burns (1994) Apoptosis induced by inhibition of intercellular contact. J Cell Biol 125: 403-415.
7. Bates, R.C., L.F. Lincz, G.F. Burns (1995) Involvement of integrins in cell survival. Cancer Metastasis Rev 14: 191-203.
8. Bates, R.C., N.S. Edwards, J.D. Yates (2000) Spheroids and cell survival. Crit Rev Oncol Hematol 36: 61-74.
9. Bates, R.C., J.D. Goldsmith, R.E. Bachelder, C. Brown, M. Shibuya, P. Oettgen, A.M. Mercurio (2003) Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. Curr Biol 13: 1721-1727.
10. Bates, R.C., A.M. Mercurio (2003) Tumor necrosis factor-α stimulates the epithelial to mesenchymal transition of human colonic organoids. Mol Biol Cell 14: 1790-1800.
11. Bates, R.C., D.I. Bellovin, C. Brown, E. Maynard, B. Wu, H. Kawakatsu, D. Sheppard, P. Oettgen, A.M. Mercurio (2005) Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 115: 339-347.
12. Bhowmick, N.A., M. Ghiassi, A. Bakin, M. Aakre, C.A. Lundquist, M.E. Engel, C.L. Arteaga, H.L. Moses (2001) Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a Rho-A-dependent mechanism. Mol Biol Cell 12: 27-36.
13. Brabletz, T., A. Jung, S. Reu, M. Porzner, F. Hlubeck, L.A. Kunz-Schugart, R. Knuechel, T. Kirchner (2001) Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor microenvironment. Proc Natl Acad Sci USA 98: 10356-10361.
14. Brabletz, T., F. Hlubek, S. Spaderna, O. Schmalhofer, E. Hiendlmeyer, A. Jung, T. Kirchner (2005a) Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and β-catenin. Cells Tissues Organs 179: 56-65.
15. Brabletz, T., A. Jung, S. Spaderna, F. Hlubek, T. Kirchner (2005b) Migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749.
16. Breuss, J.M., N. Gillett, L. Lu, D. Sheppard, R. Pytela (1993) Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues. J Histochem Cytochem 41: 1521-1527.
17. Breuss, J.M., J. Gallo, H.M. DeLisser, I.V. Klimanskaya, H.G. Folkesson, J.F. Pittet, S.L. Nishimura, K. Aldape, D.V. Landers, W. Carpenter, N. Gillett, D. Sheppard, M.A. Matthay, S.M. Albelda, R.H. Kramer, R. Pytela (1995) Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 108: 2241-2251.
18. Busk, M., R. Pytela, D. Sheppard (1992) Characterization of the integrin αvβ6 as a fibronectin-binding protein. J Biol Chem 267: 5790-5796.
19. Calvert, P.M., H. Frucht (2002) The genetics of colorectal cancer. Ann Intern Med 137: 603-612.
20. Csiszar, A., T. Szentes, B. Haraszti, W. Zou, D. Emilie, G.G. Petranyi, E. Pocsik (2001) Characterization of cytokine mRNA expression in tumor-infiltrating mononuclear cells and tumor cells freshly isolated from human colorectal carcinomas. Eur Cytokine Netw 12: 87-96.
21. Csiszar, A., T. Szentes, B. Haraszti, A. Balazs, G.G. Petranyi, E. Pocsik (2004) The pattern of cytokine gene expression in human colorectal carcinoma. Pathol Oncol Res 10: 109-116.
22. de Caestecker, M.P., E. Piek, A.B. Roberts (2000) Role of transforming growth factor-β signaling in cancer. J Natl Cancer Inst 92: 1388-1402.
23. Diaz-Rubio, E. (2004) New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers. Oncologist 9: 282-294.
24. Engle, S.J., J.B. Hoying, G.P. Boivin, I. Ormsby, P.S. Gartside, T. Doetschman (1999) Transforming growth factor beta 1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res 59: 3379-3386.
25. Etoh, T., K. Shibuta, G.F. Barnard, S. Kitano, M. Mori (2000) Angiogenin expression inhuman colorectal cancer: the role of focal macrophage infiltration. Clin Cancer Res 6: 3545-3551.
26. Fearon, E.R., B. Vogelstein (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
27. Friedl, P., K. Wolf (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374.
28. Friedl, P., Y. Hegerfeldt, M. Tusch (2004) Collective cell migration in morphogenesis and cancer. Int J Dev Biol 48: 441-449.
29. Fujimoto, K., H. Sheng, J. Shao, R.D. Beauchamp (2001) Transforming growth factor-β1 promotes invasiveness after cellular transformation with activated ras in intestinal epithelial cells. Exp Cell Res 266: 239-249.
30. Gold, L.I. (1999) The role of transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 10: 303-360.
31. Goldberg, R.M. (2005) Advances in the treatment of metastatic colon cancer. Oncologist 10(suppl 3): 40-48.
32. Goss, K.H., J. Groden (2000) Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 18: 1967-1979.
33. Gotzmann, J., M. Mikula, A. Eger, R. Schulte-Hermann, R. Foisner, H. Beug, W. Mikulits (2004) Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 566: 9-20.
34. Hamidi, S., T. Salo, T. Kainulainen, J. Epstein, K. Lerner, H. Larjava (2000) Expression of alpha(v)beta6 integrin in oral leukoplakia. Br J Cancer 82: 1433-1440.
35. Hanahan, D., R.A. Weinberg (2000) The hallmarks of cancer. Cell 100: 57-70.
36. Hasumi, Y., H. Mizukami, M. Urabe, T. Kohno, K. Takeuchi, A. Kume, M. Momoeda, H. Yoshikawa, T. Tsuruo, M. Shibuya, Y. Taketani, K. Ozawa (2002) Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer. Cancer Res 62: 2019-2023.
37. Hayward, I.P., R.H. Whitehead (1992) Patterns of growth and differentiation in the colon carcinoma cell line LIM 1863. Int J Cancer 51: 1-8.
38. Hayward, I.P., R.H. Whitehead, L. Ward, R. Gianello, P. Dempsey, R. Bates, G.F. Burns (1995) Effect of TGF-beta on differentiated organoids of the colon carcinoma cell line LIM 1863. Immunol Cell Biol 73: 249-257.
39. Hoshida, T., M. Sunamura, D.G. Duda, S. Egawa, S. Miyazaki, R. Shineha, H. Hamada, H. Ohtani, S. Satomi, S. Matsuno (2000) Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor. Pancreas 25: 111-121.
40. Hsu, S., F. Huang, M. Hafez, S. Winawer, E. Friedman (1994) Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression. Cell Growth Differ 5: 267-275.
41. Hynes, R.O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
42. Hynes, R.O. (2002) Integrins: bi-directional allosteric signaling machines. Cell 110: 673-687.
43. Janda, E., K. Lehmann, I. Killisch, M. Jechlinger, M. Herzig, J. Downward, H. Beug, S. Grunert (2002) Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of ras signaling pathways. J Cell Biol 156: 299-314.
44. Kemperman, H., M.H. Driessens, G. LaRiviere, A.M. Meijne, E. Roos (1995) Adhesion mechanisms in liver metastasis formation. Cancer Surv 24: 67-79.
45. Kinzler, K., B. Vogelstein (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170.
46. Kuo, C.J., F. Farnebo, E.Y. Yu, R. Christofferson, R.A. Swearingen, R. Carter, H.A. von Recum, J. Yuan, J. Kamihara, E. Flynn, R. D'Amato, J. Folkman, R.C. Mulligan (2001) Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci USA 98: 4606-4610.
47. Leek, R.D., C.E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, A.L. Harris (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629.
48. Lehmann, K., E. Janda, C.E. Pierreux, M. Rytomaa, A. Schulze, M. McMahon, C.S. Hill, H. Beug, J. Downward (2000) Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev 14: 2610-2622.
49. Liotta, L., E.C. Kohn (2001) The microenvironment of the tumor-host interface. Nature 411: 375-379.
50. Mahasreshti, P.J., J.G. Navarro, M. Kataram, M.H. Wang, D. Carey, G.P. Siegal, M.N. Barnes, D.M. Nettleback, R.D. Alvarez, A. Hemminki, D.T. Curiel (2001) Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma. Clin Cancer Res 7: 2057-2066.
51. Markowitz, S.D., A.B. Roberts (1996) Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 7: 93-102.
52. Markowitz, S.D., D.M. Dawson, J. Willis, J.K.V. Willson (2002) Focus on colon cancer. Cancer Cell 1: 233-236.
53. Marshall, J. (2005) The role of bevacizumab as a first-line therapy for colon cancer. Semin Oncol 32: 43-47.
54. Mercurio, A.M., R.E. Bachelder, R.C. Bates, J. Chung (2004) Autocrine signaling in carcinoma: VEGF and the α6β4 integrin. Semin Cancer Biol 14: 115-122.
55. Munger, J.S., X. Huang, H. Kawakatsu, M.J. Griffiths, S.L. Dalton, J. Wu, J.F. Pittet, N. Kaminski, C. Garat, M.A. Matthay, D.B. Rifkin, D. Sheppard (1999) The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328.
56. Nawshad, A., D. LaGamba, A. Polad, E.D. Hay (2005) Transforming growth factor-β signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 179: 11-23.
57. Naylor, M.S., G.W. Stamp, W.D. Foulkes, D. Eccles, F.R. Balkwill (1993) Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 91: 2194-2206.
58. Oft, M., J. Peli, C. Rudaz, H. Schwarz, H. Beug, E. Reichmann (1996) TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10: 2462-2477.
59. Oft, M., K.H. Heider, H. Berg (1998) TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8: 1243-1252.
60. Papadakis, K.A., S.R. Targan (2000) Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 119: 1148-1157.
61. Pilewski, J.M., J.D. Latoche, S.M. Arcasoy, S.M. Albelda (1997) Expression of integrin cell adhesion receptors during human airway epithelial repair in vivo. Am J Pathol 273: L256-L263.
62. Prieto, A.L., G.M. Edelman, K.L. Crossin (1993) Multiple integrins mediate cell attachment to cytoactin/tenascin. Proc Natl Acad Sci USA 90: 10154-10158.
63. Raz, A. (1988) Adhesive properties of metastasizing tumor cells. Ciba Found Symp 141: 323-330.
64. Reichmann, E., H. Schwarz, E.M. Deiner, I. Leitner, M. Eilers, M. Busslinger, H. Beug (1992) Activation of an inducible c-fos ER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid conversion. Cell 71: 1103-1116.
65. Regezi, J.A., D.M. Ramos, R. Pytela, N.P. Dekker, R.C.K. Jordan (2002) Tenascin and β6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 38: 332-336.
66. Savagner, P. (2001) Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23: 912-923.
67. Schiott, A., A.C.M. Johansson, B. Widegreen, H.O. Sjorgen, M. Lindvall (2000) Effects of transforming growth factor β1 expression in a rat colon carcinoma: growth inhibition, leukocyte infiltration and production of interleukin-10 and tumor necrosis factor α. Cancer Immunol Immunother 48: 579-587.
68. Schultze, A., K. Lehmann, H.B.J. Jeffries, M. McMahon, J. Downward (2001) Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev 15: 981-994.
69. Sunderkotter, C., K. Steinbrink, M. Goebeler, R. Bhardwaj, C. Sorg (1994) Macrophages and angiogenesis. J Leukoc Biol 55: 410-422.
70. Takayama, K.K., H. Ueno, Y. Nakanishi, T. Sakamoto, K. Inoue, K. Shimizu, H. Oohashi, N. Hara (2000) Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Cancer Res 60: 2169-2177.
71. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
72. Thiery, J.P. (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746.
73. Tuxhorn, J.A., G.E. Ayala, D.R. Rowley (2001) Reactive stroma in prostate cancer progression. J Urol 166: 2472-2483.
74. Vogelstein, B, E. Fearon, S. Hamilton, S.E. Kern, A.C. Preisinger, M. Leppert, Y. Nakamura, R. White, A.M. Smits, J.L. Bos (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319: 525-532.
75. Wakefield, L.M., A.B. Roberts (2002) TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29.
76. Wang, F., V.M. Weaver, O.W. Petersen, C.A. Larabell, S. Dedhar, P. Briand, R. Lupu, M.J. Bissell (1998) Reciprocal interactions between beta-1 integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95: 14821-14826.
77. Warren, R.S., H. Yuan, M.R. Matli, N.A. Gillett, N. Ferrara (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789-1797.
78. Watanabe, T., T.T. Wu, P.J. Catalano, T. Ueki, R. Satriano, D.G. Haller, A.B. Benson 3rd (2001) Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344: 1196-1206.
79. Weaver, V.M., O.W. Petersen, F. Wang, C.A. Larabell, P. Briand, C. Damsky, M.J. Bissell (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137: 231-245.
80. Whitehead, R.H., J.K. Jones, A. Gabriel, R.E. Lukies (1987) A new colon carcinoma cell line (LIM 1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. Cancer Res 47: 2683-2689.
81. Wu, S., C.M. Boyer, R.S. Whitaker, A. Berchuck, J.R. Weiner, J.B. Weinberg, R.C. Bast Jr. (1993) Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression. Cancer Res 53: 1939-1944.
82. Yang, W., S. Arii, A. Mori, K. Furumoto, T. Nakao, N. Isobe, T. Murata, H. Onodera, M. Imamura (2001) sFlt-1 gene-transfected fibroblasts: a wound specific gene therapy inhibits local cancer recurrence. Cancer Res 61: 7840-7845.
83. Yue, J., K.M. Mulder (2001) Transforming growth factor-β signal transduction in epithelial cells. Pharmacol Ther 91: 1-34.
84. Zambruno, G., P.C. Marchisio, A. Marconi, C. Vaschieri, A. Melchiori, A. Giannetti, M. DeLuca (1995) Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol 129: 853-865.
85. Zbar, A.P. (2004) The immunology of colorectal cancer. Surg Oncol 13: 45-53.